Heparegenix

Biotech & Life Sciences · Tübingen, Germany · Founded 2015

HepaRegeniX is a biotechnology company focused on discovering and developing innovative drug candidates to treat multiple liver diseases. The company's primary market includes healthcare providers, pharmaceutical companies, and research institutions. HepaRegeniX operates in the biotechnology and pharmaceutical sectors, targeting unmet medical needs in liver disease treatment. The business model revolves around the research and development of proprietary drug candidates, which are then advanced through clinical trials. Revenue is generated through funding rounds, partnerships, and potential future licensing deals or sales of developed drugs. Recently, HepaRegeniX raised a Series C funding round to further the clinical development of its lead candidate, HRX 215, aimed at liver regeneration. Keywords: biotechnology, liver disease, drug development, clinical trials, healthcare, pharmaceutical, liver regeneration, HRX 215, Series C funding, innovation.

Valuation $0–100M

Headcount <100

Total funding $50–100M

Unlock exact values

Investors

8 investors on Heparegenix's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 6 investors entered at this stage

Boehringer Ingelheim Venture Fund

Novo Seeds

HTGF

Ascenion GmbH

Novo Holdings

Coparion

Series B+ 2 investors entered at this stage

Vesalius Biocapital Partners

Wellington Partners

Global footprint

Where Heparegenix has talent and traffic

Workforce by country

5 countries with
team presence

🇩🇪 Germany61.5%

🇺🇸 United States15.4%

🇳🇴 Norway7.7%

🇩🇰 Denmark7.7%

🇱🇺 Luxembourg7.7%

5 countries shown

Talent graph

The shape of Heparegenix's talent

Dealroom maps Heparegenix's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

9 team members profilednamed & role-tagged by Dealroom

15 employeestotal headcount

5 executives & foundersidentified by name

DimensionScore

AI Talent

Engineering

Product

Go-to-market

Leadership

Research

Book a demo to unlock Heparegenix's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about Heparegenix

An AI-synthesized read of the highest-engagement posts about Heparegenix on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Heparegenix on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles